Department of Ultrasound, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Department of Obstetrics, Chongqing Health Center for Women and Children, Chongqing 400013, China.
Clin Chim Acta. 2017 Dec;475:97-101. doi: 10.1016/j.cca.2017.09.018. Epub 2017 Sep 28.
Serum gamma glutamyl transferase (GGT), produced and released mostly from the liver and bile duct, is an enzyme involved in response to oxidative stress, and has been used as a maker for prediction of cardiovascular events. Umbilical artery blood flow resistance index, e.g., the systolic/diastolic ratio (S/D ratio) as determined by ultrasound, has been used to assess the fetal intrauterine conditions. While changes of GGT and S/D ratio in preeclampsia are found to be associated with the risk for adverse perinatal outcome, the potential value of combined use of the two measurements for the prediction of adverse perinatal outcome has not been determined.
This study included severe preeclampsia patients in late pregnancy and determined their serum GGT levels and ultrasonic flow resistance index of umbilical artery within a week before delivery. Demographic data and perinatal outcomes including perinatal death, five-minute Apgar score, admission to neonatal intensive care unit, respiratory distress syndrome, and intrauterine growth restriction, are documented and analyzed.
It was found that serum GGT combined with umbilical artery S/D ratio predicted perinatal adverse outcomes in severe preeclampsia patients with a sensitivity of 94.30% and a specificity of 80.00%. Moreover, absent or reversed UA diastolic blood flow was found to be an independent risk factor for intrauterine growth restriction.
GGT in combination with umbilical artery S/D ratio is a potentially useful marker for the prediction of adverse outcome in severe preeclampsia patients. Future studies in a larger cohort of patients should be performed to verify the efficacy of the strategy. Early and accurate prediction of adverse perinatal events can facilitate the efforts to improve the perinatal outcomes of neonates associated with preeclamptic pregnancies.
血清γ-谷氨酰转移酶(GGT)主要由肝脏和胆管产生和释放,是一种参与氧化应激反应的酶,已被用作预测心血管事件的标志物。通过超声检查确定的脐动脉血流阻力指数,如收缩/舒张比值(S/D 比值),已被用于评估胎儿宫内情况。虽然子痫前期患者的 GGT 和 S/D 比值变化与不良围产儿结局的风险相关,但尚未确定两种测量值联合使用对预测不良围产儿结局的潜在价值。
本研究纳入了妊娠晚期严重子痫前期患者,并在分娩前一周内测定其血清 GGT 水平和脐动脉超声血流阻力指数。记录并分析了人口统计学数据和围产儿结局,包括围产儿死亡、5 分钟 Apgar 评分、新生儿重症监护病房入院、呼吸窘迫综合征和宫内生长受限。
发现血清 GGT 联合脐动脉 S/D 比值预测严重子痫前期患者围产儿不良结局的敏感性为 94.30%,特异性为 80.00%。此外,脐动脉舒张期血流缺失或反向被发现是宫内生长受限的独立危险因素。
GGT 联合脐动脉 S/D 比值是预测严重子痫前期患者不良结局的一种潜在有用的标志物。未来应在更大的患者队列中进行研究,以验证该策略的疗效。早期、准确地预测不良围产儿事件有助于改善与子痫前期相关的新生儿的围产儿结局。